ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Criticized For Delays In Development Of New Drugs

January 24, 1975

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

Obama Picks Daschle for HHS Secretary. Waxman Gains Chairmanship of Energy & Commerce.

November 21, 2008

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Orlando Hospital Severs MD Anderson Ties, Forming Center with University of Florida

January 10, 2014

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000